Fascin-Associated Mechanisms in Cancer Cell Migration

Fascin is a conserved actin-bundling protein that orchestrates the assembly of filopodia, lamellipodia and invadopodia at the leading edge of migrating cancer cells. By stabilising parallel actin bundles, fascin enhances protrusive force and directional persistence, enabling cells to navigate the extracellular matrix. Dysregulated fascin expression correlates with aggressive tumour phenotypes, poor prognosis and heightened metastatic potential across diverse carcinomas. Mechanistically, fascin’s actin-cross-linking activity is modulated by post-translational modifications such as phosphorylation at serine residues, which alter its binding affinity and bundle architecture. Recent structural studies reveal that fascin exhibits nanoscale conformational plasticity, accommodating filament spacing and helical mismatches within bundles. This structural adaptability underlies the formation of robust actin cables that support membrane protrusions. Extracellular signals, including cytokines and metabolic cues, can trigger translocation of fascin between subcellular compartments, coordinating with pathways mediated by β-catenin and other scaffolding proteins. Pharmacological targeting of fascin through small-molecule inhibitors impairs filopodial assembly and suppresses invasion, offering a promising avenue for anti-metastatic therapy. Advances in imaging, biophysical assays and in vivo models have begun to connect the molecular choreography of fascin with tumour cell mechanics, highlighting its central role in the metastatic cascade.

Research from Nature Portfolio

High-resolution cryo-electron microscopy and tomography studies have revealed how human fascin-1 cross-links actin filaments within micron-scale bundles. The asymmetric binding conformation is allosterically hindered by a small-molecule inhibitor termed G2, while computational analyses demonstrate that fascin’s structural plasticity accommodates varied interfilament orientations, reconciling filament helical symmetry with hexagonal packing rules that limit bundle size. Complementary high-throughput chemical screening has identified fascin inhibitors that block its actin-bundling function, abolishing filopodia formation, cell migration and in vivo metastatic colonisation, thereby validating fascin as a direct anti-invasion target.

Fascin-Associated Mechanisms in Cancer Cell Migration publication trend

The graph below shows the total number of articles in fascin-associated mechanisms in cancer cell migration across all publications each year (not limited to Nature Index journals).

Technical terms

Fascin: An actin-bundling protein that cross-links filaments into parallel cables essential for membrane protrusions.

Filopodia: Thin, actin-rich surface extensions that sense the environment and guide cell movement.

Lamellipodia: Sheet-like cytoskeletal protrusions driven by branched actin networks, facilitating broad-based migration.

Invadopodia: Actin-based protrusions specialised for extracellular matrix degradation during tumour invasion.

β-catenin: A multifunctional protein involved in cell adhesion and transcriptional regulation, which influences fascin localisation.

References

1. Lactate-mediated Fascin protrusions promote cell adhesion and migration in cervical cancer. Theranostics (2023).
2. Fascin structural plasticity mediates flexible actin bundle construction. Nature Structural & Molecular Biology (2025).
3. Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis. BMC Medicine (2013).
4. Targeted inhibition of fascin function blocks tumour invasion and metastatic colonization. Nature Communications (2015).
5. Fascin-1 in Cancer Cell Metastasis: Old Target-New Insights. International Journal of Molecular Sciences (2023).
6. Mechanism of Actin Filament Bundling by Fascin*. Journal of Biological Chemistry (2011).
7. Identification of an Actin Binding Region and a Protein Kinase C Phosphorylation Site on Human Fascin*. Journal of Biological Chemistry (1997).